NCPA Media: Health Care

  • Jul 20, 2016

    Medicare’s “Doc Fix” Won’t Fix Much

    Initial Assessments Reveal Increased Regulation, Costs: NCPA

    Dallas, TX (7/20/2016) – The “doc fix” contained in the Medicare Access and CHIP Reauthorization Act (MACRA) is fiscally irresponsible, and will only increase federal control over how doctors practice medicine, warns a new report by National Center for Policy Analysis Senior Fellow John R. Graham.


  • Jul 08, 2016

    How Congress Can Curb Opioid Abuse: NCPA Report

    E-prescribing is Key to Reducing Fraud & Abuse

    Dallas, TX (7/8/2016) – Today’s vote on a House bill to reduce opioid abuse did not include a key solution to the growing opioid pan reliever epidemic: mandatory electronic prescribing. E-prescribing would make a significant dent in the rate of fraud, resale and abuse of opioids, according to a new study by National Center for Policy Analysis Senior Fellow Devon Herrick.


  • Jun 21, 2016

    Cutting Competition Won’t Solve the Problem of Rising Drug Prices

    Overregulating Drug Plans Could Raise Costs to Consumers: NCPA

    Dallas, TX

    Would requiring disclosure of wholesale prices lower prescription drug costs? Experts say no, according to a new report by National Center for Policy Analysis Senior Fellow Devon Herrick.

    In a misguided attempt to combat the high prices of some new and specialty drugs, a few politicians and trade lobbyists for pharmacies and drug makers have begun to blame high drug prices on the administrators of employee drug plans – suggesting drug plans are not passing on their discounts to consumers and employers.

    This “bogus argument” posits that drug prices would be lower if drug plans were required to disclose the wholesale prices – a requirement that would be detrimental to any wholesale industry.

    Regardless of the industry, wholesale prices are often negotiated among private parties and are generally considered proprietary. “If competing hardware stores knew the exact wholesale prices Home Depot negotiated with suppliers, all competing stores would bargain aggressively for the same price. Over time, the likely result is that manufacturers would ultimately set one uniform wholesale price higher than the price volume purchasers would otherwise obtain,” says Herrick.

    The end result? Highly competitive firms would no longer be able to leverage buying power and pass on discounted prices to consumers.

    “Drugs are affordable for most consumers because of competition among Pharmacy Benefit Managers (PBMs),” adds Herrick. “Taking away PBMs’ ability to compete by regulating price transparency would harm consumers in the long run."

    A Bogus Solution for High Drug Costs: http://www.ncpa.org/pub/a-bogus-solution-for-high-drug-costs


  • Jun 02, 2016

    Raising premiums, deductibles may help control Medicare spending, experts say

    NCPA research recently released in the report “How to Pay for Medicare” was cited in this article from McKnight’s.


  • May 31, 2016

    How to Pay for Medicare

    Four reforms could rein in Medicare spending growth: NCPA

    NCPA: Rising numbers of retirees and excess cost growth have made it imperative that we chance how the Medicare is financed – or the cost burden will crush taxpayers, according to a new study by NCPA Senior Fellows Andrew J. Rettenmaier and Thomas R. Saving.


  • May 30, 2016

    Pharmacists group pushing for expanded ‘preferred’ Medicare networks

    Arizona Business Daily: Preferred networks are at the root of how benefits managers have lowered drug costs for Medicare recipients, says NCPA Senior Fellow Devon Herrick in this article from Arizona Business Daily.


  • May 24, 2016

    As national pharmacy group lobbies for Lipinski-backed bill, critics say measure would raise drug prices

    West Cook News: NCPA Senior Fellow Devon Herrick is cited in this article from West Cook News on why recent legislation would “weaken the tools insurers and PBMs use to negotiate low drug prices with pharmacies on consumers’ behalf.”


  • May 24, 2016

    Critics claim Deutch-backed Medicare pharmacy bill would lead to higher drug prices for seniors

    Florida Business Daily: NCPA Senior Fellow Devon Herrick is cited on efforts from pharmacies to affect legislation in order to allow them to charge more in this article from Florida Business Daily.




porno izle